Article Text

other Versions

PDF
How much could a microbicide’s STI-efficacy contribute to reducing HIV-risk and the level of condom use needed to lower risk? Model estimates
  1. Anna Mary Foss (anna.foss{at}lshtm.ac.uk)
  1. London School of Hygiene and Tropical Medicine, United Kingdom
    1. Peter Thomas Vickerman (peter.vickerman{at}lshtm.ac.uk)
    1. London School of Hygiene and Tropical Medicine, United Kingdom
      1. Michel Alary (malary{at}uresp.ulaval.ca)
      1. Centre Hospitalier Affilié Universitaire de Québec, Canada
        1. Charlotte Helen Watts (charlotte.watts{at}lshtm.ac.uk)
        1. London School of Hygiene and Tropical Medicine, United Kingdom

          Abstract

          Objective: This study explores the potential contribution of a microbicide’s STI-efficacy in reducing a female sex worker’s (FSW’s) risk of STI and HIV infection. The study then investigates whether the threshold, for the reduction in condom use following microbicide introduction that can be tolerated without increasing HIV-risk, is affected by the STI-efficacy.

          Methods: A dynamic model describing the transmission of a bacterial STI between FSWs and their clients was coupled with a static HIV model. The model uses data from Cotonou, Benin (1998-99), for illustration, to estimate the change in risk following the introduction of 50% HIV-efficacious microbicides of different STI-efficacies, used in 50% of sex acts when a condom is not used. The condom migration thresholds were estimated. The degree to which the findings are influenced by STI prevalence was explored.

          Results: For highly transmissible STIs, there is a non-monotonic relationship between STI prevalence and microbicide impact on HIV with the relative reduction in HIV-risk first increasing, due to the proportion of HIV-risk attributable to the STI increasing, but then decreasing at high prevalences as the STI becomes harder to control. A less transmissible STI can still be impacted upon with a moderate/high STI-efficacy microbicide even at high STI prevalences. This relationship is also reflected in the condom migration thresholds.

          Conclusions: A microbicide’s STI-efficacy may have a substantial impact on STI and HIV incidence among high-risk groups. The variation in the condom migration thresholds for different STI-efficacies and STI prevalences may be difficult to accurately measure.

          Statistics from Altmetric.com

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.